Abstract
Great hopes are being placed on regenerative medicine providing the next generation of therapies that can treat patients with incurable disease. At present, culturing of cells for regenerative medicine is mainly performed manually. Automated culture of cells for medical use is the greatest challenge in safe and large–scale production toward wider adoption of regenerative medicine. The closed systems for automated culture equipment developed by Hitachi can produce cell sheets with quality equivalent to that of manual culture. Hitachi has also developed cell sheet transportation container that can maintain sterility, constant temperature and pressure. These researches and developments can facilitate the spread of regenerative medicine to deliver high–quality cells to patients around the world.
